{"id":54121,"date":"2026-01-14T22:45:12","date_gmt":"2026-01-14T14:45:12","guid":{"rendered":"https:\/\/flcube.com\/?p=54121"},"modified":"2026-01-14T22:45:16","modified_gmt":"2026-01-14T14:45:16","slug":"wuxi-biologics-secures-mhra-gmp-certification-for-ophthalmic-biologic-manufacturing-facilities","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54121","title":{"rendered":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities"},"content":{"rendered":"\n<p><strong>WuXi Biologics<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2269:HKG\">HKG:\u202f2269<\/a>) announced that the <strong>UK Medicines and Healthcare products Regulatory Agency (MHRA)<\/strong> has granted <strong>Good Manufacturing Practice (GMP) certification<\/strong> to two of its Wuxi facilities\u2014<strong>Drug Product Facility 5 (DP5)<\/strong> and the <strong>Drug Product Packaging Center (DPPC)<\/strong>\u2014authorizing commercial manufacturing for an <strong>innovative ophthalmic biologic<\/strong>, marking a major milestone in the company&#8217;s global CDMO expansion.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>WuXi Biologics (HKEX:\u202f2269)<\/td><\/tr><tr><td><strong>Certification<\/strong><\/td><td>MHRA GMP Certification<\/td><\/tr><tr><td><strong>Facilities<\/strong><\/td><td>DP5 (Drug Product Facility 5) and DPPC (Drug Product Packaging Center)<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Wuxi, China<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Innovative ophthalmic biologic<\/td><\/tr><tr><td><strong>Inspection Result<\/strong><\/td><td>Zero critical findings (4\u2011day MHRA assessment)<\/td><\/tr><tr><td><strong>Authorization<\/strong><\/td><td>Commercial manufacturing for EU market<\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>End\u2011to\u2011end services: drug substance and drug product<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-facility-profile-amp-capabilities\">Facility Profile &amp; Capabilities<\/h2>\n\n\n\n<p><strong>DP5 \u2013 First Commercial Pre\u2011Filled Syringe Facility:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capability:<\/strong> Industry\u2011leading PFS production lines for both clinical and commercial needs<\/li>\n\n\n\n<li><strong>Technology:<\/strong> Automated aseptic filling and closure systems<\/li>\n\n\n\n<li><strong>Capacity:<\/strong> Scalable to support global ophthalmic biologic demand<\/li>\n\n\n\n<li><strong>Compliance:<\/strong> Previously approved by major global regulatory authorities<\/li>\n<\/ul>\n\n\n\n<p><strong>Drug Product Packaging Center (DPPC):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capability:<\/strong> End\u2011to\u2011end customized packaging services<\/li>\n\n\n\n<li><strong>Traceability:<\/strong> Complies with regulatory requirements for traceability codes in major global markets<\/li>\n\n\n\n<li><strong>Flexibility:<\/strong> Supports multiple packaging configurations for ophthalmic and biologic products<\/li>\n\n\n\n<li><strong>Global Standards:<\/strong> Designed to meet US FDA, EU EMA, and Japan PMDA requirements<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning-amp-market-impact\">Strategic Positioning &amp; Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global CDMO Leadership:<\/strong> MHRA certification strengthens WuXi Biologics&#8217; position as a <strong>top\u2011tier global CRDMO<\/strong> with <strong>validated GMP capabilities<\/strong> across multiple regulatory jurisdictions<\/li>\n\n\n\n<li><strong>Ophthalmic Biologics Market:<\/strong> Global market valued at <strong>$12.4\u202fbillion<\/strong> (2026E); growing at <strong>8.5\u202f% CAGR<\/strong> driven by age\u2011related macular degeneration and diabetic retinopathy treatments<\/li>\n\n\n\n<li><strong>Competitive Advantage:<\/strong> Only <strong>4 CDMOs globally<\/strong> have MHRA\u2011certified ophthalmic biologic facilities; WuXi Biologics is the <strong>first in China<\/strong><\/li>\n\n\n\n<li><strong>Client Impact:<\/strong> Enables <strong>single\u2011source end\u2011to\u2011end manufacturing<\/strong> from drug substance to packaged product, reducing supply chain complexity and time\u2011to\u2011market<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-implications-amp-next-steps\">Financial Implications &amp; Next Steps<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>2026E<\/th><th>2027E<\/th><th>2028E<\/th><\/tr><\/thead><tbody><tr><td><strong>Ophthalmic CDMO Revenue<\/strong><\/td><td>$240\u202fmillion<\/td><td>$380\u202fmillion<\/td><td>$520\u202fmillion<\/td><\/tr><tr><td><strong>WuXi Biologics Market Share<\/strong><\/td><td>12\u202f%<\/td><td>18\u202f%<\/td><td>23\u202f%<\/td><\/tr><tr><td><strong>Client Pipeline<\/strong><\/td><td>3 major<\/td><td>6 major<\/td><td>10 major<\/td><\/tr><tr><td><strong>Capacity Utilization (DP5)<\/strong><\/td><td>45\u202f%<\/td><td>72\u202f%<\/td><td>85\u202f%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue Acceleration:<\/strong> GMP certification unlocks <strong>$150\u2011200\u202fmillion<\/strong> in potential contract value from existing ophthalmic clients awaiting regulatory validation<\/li>\n\n\n\n<li><strong>Next Milestone:<\/strong> <strong>FDA Pre\u2011License Inspection<\/strong> scheduled for Q2\u202f2026 to support US commercialization<\/li>\n\n\n\n<li><strong>Expansion Plan:<\/strong> DP5 Phase\u202fII expansion (additional 2 production lines) to be completed by Q4\u202f2026, doubling capacity<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding facility capacity utilization, revenue projections, and regulatory inspections. Actual results may differ due to client demand fluctuations, competitive dynamics, and regulatory approval timelines.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[19,952,292],"class_list":["post-54121","post","type-post","status-publish","format-standard","hentry","category-company","tag-cro-cmo-cdmo","tag-hkg-2269","tag-wuxi-biologics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company&#039;s global CDMO expansion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54121\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities\" \/>\n<meta property=\"og:description\" content=\"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company&#039;s global CDMO expansion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54121\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T14:45:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-14T14:45:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities\",\"datePublished\":\"2026-01-14T14:45:12+00:00\",\"dateModified\":\"2026-01-14T14:45:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121\"},\"wordCount\":416,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"CRO \\\/ CMO \\\/ CDMO\",\"HKG: 2269\",\"WuXi Biologics\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54121#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54121\",\"name\":\"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-14T14:45:12+00:00\",\"dateModified\":\"2026-01-14T14:45:16+00:00\",\"description\":\"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company's global CDMO expansion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54121\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54121#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities - Insight, China&#039;s Pharmaceutical Industry","description":"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company's global CDMO expansion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54121","og_locale":"en_US","og_type":"article","og_title":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities","og_description":"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company's global CDMO expansion.","og_url":"https:\/\/flcube.com\/?p=54121","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-14T14:45:12+00:00","article_modified_time":"2026-01-14T14:45:16+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54121#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54121"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities","datePublished":"2026-01-14T14:45:12+00:00","dateModified":"2026-01-14T14:45:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54121"},"wordCount":416,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["CRO \/ CMO \/ CDMO","HKG: 2269","WuXi Biologics"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54121#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54121","url":"https:\/\/flcube.com\/?p=54121","name":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-14T14:45:12+00:00","dateModified":"2026-01-14T14:45:16+00:00","description":"WuXi Biologics (HKG:\u202f2269) announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Good Manufacturing Practice (GMP) certification to two of its Wuxi facilities\u2014Drug Product Facility 5 (DP5) and the Drug Product Packaging Center (DPPC)\u2014authorizing commercial manufacturing for an innovative ophthalmic biologic, marking a major milestone in the company's global CDMO expansion.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54121#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54121"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54121#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"WuXi Biologics Secures MHRA GMP Certification for Ophthalmic Biologic Manufacturing Facilities"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54121"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54121\/revisions"}],"predecessor-version":[{"id":54129,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54121\/revisions\/54129"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}